Sidrak, M.M.A.; De Feo, M.S.; Corica, F.; Gorica, J.; Conte, M.; Filippi, L.; Schillaci, O.; De Vincentis, G.; Frantellizzi, V.
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review. Int. J. Mol. Sci. 2023, 24, 3863.
https://doi.org/10.3390/ijms24043863
AMA Style
Sidrak MMA, De Feo MS, Corica F, Gorica J, Conte M, Filippi L, Schillaci O, De Vincentis G, Frantellizzi V.
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review. International Journal of Molecular Sciences. 2023; 24(4):3863.
https://doi.org/10.3390/ijms24043863
Chicago/Turabian Style
Sidrak, Marko Magdi Abdou, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, and Viviana Frantellizzi.
2023. "Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review" International Journal of Molecular Sciences 24, no. 4: 3863.
https://doi.org/10.3390/ijms24043863
APA Style
Sidrak, M. M. A., De Feo, M. S., Corica, F., Gorica, J., Conte, M., Filippi, L., Schillaci, O., De Vincentis, G., & Frantellizzi, V.
(2023). Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review. International Journal of Molecular Sciences, 24(4), 3863.
https://doi.org/10.3390/ijms24043863